PamGene

About:

PamGene is an European biotechnology company.

Website: https://www.pamgene.com/

Twitter/X: PamGenecom

Top Investors: EQT Life Sciences, Alta Partners, Gimv, Eurostars, LCF Rothschild

Description:

PamGene has a unique proprietary array-based platform to measure the activities of kinases & nuclear receptors, enabling deeper understanding of drug interactions with these important classes of signalling molecules. PamGene's patented technology finds a wide range of applications including lead identification and optimization, (pre) clinical translational research and biomarker development.

Total Funding Amount:

19.7M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

's-hertogenbosch, Noord-Brabant, The Netherlands

Founded Date:

2000-01-01

Contact Email:

info(AT)pamgene.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-01-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai